From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
about
The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouseDeficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig.The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Serum Prolactin Levels in Patients with Major Depressive Disorder Receiving Selective Serotonin-Reuptake Inhibitor Monotherapy for 3 Months: A Prospective StudyA cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.Sex differences in plasma prolactin response to tryptophan in chronic fatigue syndrome patients with and without comorbid fibromyalgiaUnilateral Galactorrhea Associated with Low-dose EscitalopramEndocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.Hyperprolactinemia with antipsychotic drugs in children and adolescents.Antidepressant use and circulating prolactin levelsPharmacological causes of hyperprolactinemiaProlactin and dopamine: what is the connection? A review article.Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot studyAmphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of FluoxetineSelective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.Review of the epidemiological literature on antidepressant use and breast cancer risk.Use of antidepressant medications in relation to the incidence of breast cancer.Iron deficiency in pediatric patients in long-term risperidone treatmentMood disorders and fertility in women: a critical review of the literature and implications for future research.Serotoninergic and Circadian Systems: Driving Mammary Gland Development and Function.Selective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non-human primates.Endobiogeny: a global approach to systems biology (part 2 of 2)A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case seriesDrug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.Safety and tolerability review of lorcaserin in clinical trials.Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine.Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea.Depression, antidepressant use and breast cancer risk in pre- and postmenopausal women: a prospective cohort study.(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects?Pilot study on sex hormone levels and fertility in women with malignant gliomas.Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database.No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients.Male Reproductive Functions Disrupted by Pharmacological Agents.
P2860
Q26849351-A3ACCE6D-C09B-40CC-9DA2-4F31C34C9B6DQ30531298-5832B1AA-3D20-4E32-8506-6E52CE7CD63FQ33294801-1B040CFB-31BA-4153-A013-A66777B4FE1CQ33619940-3B40A031-02CE-4412-9C1B-8BACC119B91AQ33715087-BEADE0F5-6CB4-4DC5-8321-5F991110C908Q33755068-028F2816-7812-4610-A1A2-BEA47DC1BEEFQ33874989-54602679-3573-4F65-BB00-CF8E61BE22D9Q33908871-2BDAD1ED-5B11-4FFD-B945-1D7F5A07DBEDQ34035262-6200991C-A1E6-4DAF-87AC-B5363BE690B5Q34143459-18D849E0-A54A-491F-8ADB-7EB8F885A499Q34525990-981E8FCC-5F45-47DD-82CA-DDB52204C00EQ34778045-ACE70737-E389-478C-A77F-FED3A0969BAFQ34778434-2C1F989E-E5D0-4F64-946C-AE65FD259DC5Q35016170-C3A8656C-F695-4B1C-836F-5752FD23DA73Q35061572-023DFF10-6386-46EB-8A89-D10F0A1A2D6DQ35649527-4F382F8D-9C77-4FBA-A473-8A40BC5D2112Q35754068-3820808B-071A-40D6-9A71-BB595E3B037FQ36325444-C207A9E8-4438-4BB4-89FE-F9340D1B6312Q36445716-7FAB5022-CB09-4FB8-A6DC-DE18DAA345CEQ36607352-31F298EC-EFF6-479D-BFC2-729A767295A7Q36614001-653D9A64-13B1-41FF-B5BB-327DE4ECBC4CQ36720726-7206692A-26F7-4F67-80F3-7D4E254232E1Q36951416-5A79E6BC-3744-4507-AF37-7981E2AD3AD0Q37095999-A81D0056-939D-4641-8648-885621589D28Q37255555-335557C2-05FF-4703-A786-A34A2167B4E5Q37323903-C73B50CE-A73F-4961-A3B0-A9AFEA63AE5FQ37343584-3486478B-911D-448B-8BCF-90739E099AF8Q38100267-155BA765-4BAA-48F3-A21B-B30082FA4E66Q38954263-38380F93-88AD-463B-8A14-E9D34CD82415Q42352464-5F5AC6AD-950B-4B9A-8C89-8A3F11B0D6C2Q42577125-4251338C-09E3-4700-B989-85C01FF878A1Q47672990-4A1BAC1A-D1FA-4851-A730-1AC4B2BBE995Q47777762-F468C53A-B3E6-41EA-8821-D250F351A0CFQ48398177-1D39EBFD-A86A-45F8-A5BA-81FBE9F200CAQ48540872-C71BFE37-95F8-4218-B05F-79B518277FB7Q51389863-04154B54-2976-4557-AC7A-E4BE1C36BF91Q51749233-B94A004C-1E76-4D9B-9C1F-997F1110933AQ52687141-2A961C22-06D6-417B-A867-427142B050A4
P2860
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
@ast
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
@en
type
label
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
@ast
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
@en
prefLabel
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
@ast
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
@en
P2860
P356
P1476
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions
@en
P2093
Ana B F Emiliano
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300412
P407
P577
2004-05-01T00:00:00Z